Details for New Drug Application (NDA): 050754
✉ Email this page to a colleague
NDA 050754 describes AMOXIL, which is a drug marketed by Glaxosmithkline and Us Antibiotics and is included in eight NDAs. It is available from five suppliers. Additional details are available on the AMOXIL profile page.
The generic ingredient in AMOXIL is amoxicillin. There are forty-six drug master file entries for this compound. Thirty-nine suppliers are listed for this compound. Additional details are available on the amoxicillin profile page.
The generic ingredient in AMOXIL is amoxicillin. There are forty-six drug master file entries for this compound. Thirty-nine suppliers are listed for this compound. Additional details are available on the amoxicillin profile page.
Summary for 050754
| Tradename: | AMOXIL |
| Applicant: | Us Antibiotics |
| Ingredient: | amoxicillin |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 050754
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 875MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Jul 10, 1998 | TE: | RLD: | Yes | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Jul 10, 1998 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
